产品
编 号：F510896
产品类型
规格
价格
是否有货
100mg
询价
询价
结构图
CAS No: 9001-00-7
产品详情
生物活性：
Bromelain is an anti-inflammatory agent derived from pineapple stem that acts through down-regulation of plasma kininogen, inhibition of Prostaglandin E2 expression, degradation of advanced glycation end product receptors and regulation of angiogenic biomarkers as well as antioxidant action upstream in the COX-pathway. Bromelain exhibits various fibrinolytic, antiedematous, antithrombotic, and anti-inflammatory activities. Bromelain also possesses some anticancerous activities and promotes apoptotic cell death.
体内研究：
Bromelain (40 mg/kg；腹膜内注射；每天；持续 7 天；雄性 Sprague-Dawley 大鼠) 预处理可减少帕金森病 (PD) 大鼠模型的运动功能障碍。6-OHDA 注射会导致明显的运动障碍，而在损伤前用 Bromelain 进行预处理可以预防这种损伤。Animal Model:Male Sprague-Dawley rats injected with 6-OHDA
Dosage:40 mg/kg
Administration:Intraperitoneal injection; daily; for 7 days
Result:Reduced the motor dysfunction in the parkinsonian rat model of parkinson's disease (PD).
Bromelain is an anti-inflammatory agent derived from pineapple stem that acts through down-regulation of plasma kininogen, inhibition of Prostaglandin E2 expression, degradation of advanced glycation end product receptors and regulation of angiogenic biomarkers as well as antioxidant action upstream in the COX-pathway. Bromelain exhibits various fibrinolytic, antiedematous, antithrombotic, and anti-inflammatory activities. Bromelain also possesses some anticancerous activities and promotes apoptotic cell death.
体内研究：
Bromelain (40 mg/kg；腹膜内注射；每天；持续 7 天；雄性 Sprague-Dawley 大鼠) 预处理可减少帕金森病 (PD) 大鼠模型的运动功能障碍。6-OHDA 注射会导致明显的运动障碍，而在损伤前用 Bromelain 进行预处理可以预防这种损伤。Animal Model:Male Sprague-Dawley rats injected with 6-OHDA
Dosage:40 mg/kg
Administration:Intraperitoneal injection; daily; for 7 days
Result:Reduced the motor dysfunction in the parkinsonian rat model of parkinson's disease (PD).
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备